RxDoctor Payments DataLook up a doctor →

Amrendra Kumar, MD

Family Medicine · Lancaster, SCNPI 1104902154

Payments from drug & device makers

$1,265,581in general payments, 2019–2025

Across 182 payments — averaging $6953.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$406K
  • GSK$376K
  • Diasorin Molecular LLC$285K
  • Sanofi US Services Inc.$84K
  • Chiesi USA, Inc.$48K
  • Cue Health Inc.$41K
  • plus $25K from 13 others
$8,194in research payments, 2019–2025

Across 3 payments — averaging $2731.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$8K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,265,581 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$73,853
Medicare patients
220
Services billed
1,340

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Lancaster

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →